ラベタロール 化学特性,用途語,生産方法
効能
血圧降下薬, α1β遮断薬
説明
Labetalol is an α-adrenergic and α-1 blocking agent
which caused contact dermatitis and a contact anaphylactoid
reaction during patch testing in a nurse.
使用
Labetalol is used to treat essential hypertension.
定義
ChEBI: A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure.
生物学の機能
Labetalol (Normodyne, Trandate) possesses both -
blocking and β-blocking activity and is approximately
one-third as potent as propranolol as a -blocker and
one-tenth as potent as phentolamine as an -blocker.
The ratio of β- to α-activity is about 3:1 when labetalol
is administered orally and about 7: 1 when it is administered
intravenously. Thus the drug can be most conveniently
thought of as a β -blocker with some -blocking
properties.
一般的な説明
Labetalol is a phenylethanolamine derivative, is representative of a classof drugs that act as competitive blockers at α1-, β1-, andβ2-receptors. It is a more potent β-blocker than α-blocker.Because it has two asymmetric carbon atoms (1 and 1' ), it existsas a mixture of four isomers. It is this mixture that is usedclinically in treating hypertension. The different isomers,however, possess different α- and β-blocking activities. The -blocking activity resides solely in the (1R,1 'R) isomer,whereas the 1-blocking activity is seen in the (1S,1 R) and(1S,1'S) isomers, with the (1S,1'R) isomer possessing thegreater therapeutic activity.
接触アレルゲン
This beta-adrenergic and alpha-1 blocking agent
caused contact dermatitis and a contact anaphylactoid
reaction during patch testing in a nurse.
作用機序
Labetalol produces equilibrium-competitive antagonism
at β-receptors but does not exhibit selectivity for β1- or β2-receptors. Like certain other β-blockers (e.g., pindolol
and timolol), labetalol possesses some degree of
intrinsic activity. This intrinsic activity, or partial agonism,
especially at β2-receptors in the vasculature, has
been suggested to contribute to the vasodilator effect
of the drug. The membrane-stabilizing effect, or local
anesthetic action, of propranolol and several other β-blockers, is also possessed by labetalol, and in fact the
drug is a reasonably potent local anesthetic.
Labetalol appears to produce relaxation of vascular
smooth muscle not only by α-blockade but also by a
partial agonist effect at β2-receptors. In addition, labetalol
may produce vascular relaxation by a direct
non–receptor-mediated effect.
Labetalol can block the neuronal uptake of norepinephrine
and other catecholamines. This action, plus its
slight intrinsic activity at α-receptors, may account for
the seemingly paradoxical, although infrequent, increase
in blood pressure seen on its initial administration.
薬物動態学
Labetalol is almost completely absorbed from the gastrointestinal
tract. However, it is subject to considerable
first-pass metabolism, which occurs in both the gastrointestinal
tract and the liver, so that only about 25%
of an administered dose reaches the systemic circulation.
While traces of unchanged labetalol are recovered
in the urine, most of the drug is metabolized to inactive
glucuronide conjugates.The plasma half-life of labetalol
is 6 to 8 hours, and the elimination kinetics are essentially
unchanged in patients with impaired renal failure.
臨床応用
Labetalol is a clinically usefulantihypertensive agent. The rationale for its use in themanagement of hypertension is that its α-receptor–blockingeffects produce vasodilation and its β-receptor–blockingeffects prevent the reflex tachycardia usually associated withvasodilation. Although labetalol is very well absorbed, it undergoesextensive first-pass metabolism.
副作用
There have been reports of excessive hypotension and
paradoxical pressor effects following intravenous administration
of labetalol. These latter effects may be
due to a labetalol-induced blockade of neuronal amine
uptake, which increases the concentrations of norepinephrine
in the vicinity of its receptors.
Approximately 5% of the patients who receive labetalol
complain of side effects typical of noradrenergic
nervous system suppression. These include postural hypotension,
gastrointestinal distress, tiredness, sexual
dysfunction, and tingling of the scalp. Most of these effects
are related to α-blockade, although the tingling of
the scalp may be due to the drug’s intrinsic activity at α-receptors. Side effects associated with β-blockade, such
as induction of bronchospasm and congestive heart failure,
may also occur, but generally at a lower frequency
than -receptor–associated effects.
Skin rashes have been reported, as has an increase
in the titer of antinuclear antibodies. Despite the latter
observation, the appearance of a systemic lupus syndrome
is rare. Labetalol also has been reported to interfere
with chemical measurements of catecholamines
and metabolites.
ラベタロール 上流と下流の製品情報
原材料
準備製品